Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NSE - Delayed Quote INR

ONESOURCE SPECL PHARMA L (ONESOURCE.NS)

Compare
1,238.20
-45.40
(-3.54%)
At close: February 28 at 3:30:01 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
Total Revenue
1,719,190
1,719,190
387,140
Cost of Revenue
705,090
705,090
204,110
Gross Profit
1,014,100
1,014,100
183,030
Operating Expense
2,579,350
2,579,350
2,341,850
Operating Income
-1,565,250
-1,565,250
-2,158,820
Net Non Operating Interest Income Expense
-875,310
-875,310
-459,660
Pretax Income
-3,656,970
-3,656,970
-4,156,450
Net Income Common Stockholders
-3,911,650
-3,911,650
-7,998,300
Diluted NI Available to Com Stockholders
-3,911,650
-3,911,650
-7,998,300
Basic EPS
-34.18
--
-69.89
Diluted EPS
-34.18
--
-69.89
Basic Average Shares
114,436.02
--
114,436.02
Diluted Average Shares
114,436.02
--
114,436.02
Rent Expense Supplemental
26,850
26,850
10,840
Total Expenses
3,284,440
3,284,440
2,545,960
Net Income from Continuing & Discontinued Operation
-3,911,650
-3,911,650
-7,998,300
Normalized Income
-2,438,740
-2,438,740
-2,708,920
Interest Income
19,170
19,170
15,790
Interest Expense
853,990
853,990
401,060
Net Interest Income
-875,310
-875,310
-459,660
EBIT
-2,802,980
-2,802,980
-3,755,390
EBITDA
-1,849,180
-1,849,180
-2,614,380
Reconciled Cost of Revenue
705,090
705,090
204,110
Reconciled Depreciation
953,800
953,800
1,141,010
Net Income from Continuing Operation Net Minority Interest
-3,656,970
-3,656,970
-4,156,450
Total Unusual Items Excluding Goodwill
-1,218,230
-1,218,230
-1,447,530
Total Unusual Items
-1,218,230
-1,218,230
-1,447,530
Normalized EBITDA
-630,950
-630,950
-1,166,850
3/31/2023 - 1/24/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CONCORDBIO.NS Concord Biotech Limited
1,496.10
-5.86%
 
BCAX Bicara Therapeutics Inc.
13.30
+7.61%
 
RLYB Rallybio Corporation
0.7223
-2.39%
 
IMTX Immatics N.V.
4.3800
0.00%
 
PTGX Protagonist Therapeutics, Inc.
37.59
+3.44%
 
ENSC Ensysce Biosciences, Inc.
5.39
+2.67%
 
SION Sionna Therapeutics, Inc.
13.77
-6.71%
 
NKTR Nektar Therapeutics
0.8400
+5.50%
 
RIGL Rigel Pharmaceuticals, Inc.
23.06
+5.88%
 
ALLO Allogene Therapeutics, Inc.
1.9500
0.00%